Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

2018-2025 Porcine Vaccine Report on Global and United States Market , Status and Forecast, by Players, Types and Applications

  • QYR2511261
  • 120 Pages
  • March 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Summary

This report studies the Porcine Vaccine market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Porcine Vaccine market by product type and application/end industries.

The global Porcine Vaccine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Porcine Vaccine.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Porcine Vaccine in these regions, from 2013 to 2025 (forecast), covering

United States

North America

Europe

Asia-Pacific

South America

Middle East and Africa

The major players in global and United States market, including

Bayer AG.

Bimeda Animal Health

Boehringer Ingelheim GmbH

Ceva Sante Animale

Eli Lilly

Merck & Co., Inc.

Merial (Sanofi)

Vetoquinol

Zoetis, Inc.

On the basis of product, the market is primarily split into

Inactivated Vaccines

Live Attenuated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Conjugate Vaccines

DNA Vaccines

On the basis on the end users/application, this report covers

Veterinary Hospitals

Hog/Pig Production Farm

Table of Contents

2018-2025 Porcine Vaccine Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

1 Methodology and Data Source

1.1 Methodology/Research Approach

1.1.1 Research Programs/Design

1.1.2 Market Size Estimation

1.1.3 Market Breakdown and Data Triangulation

1.2 Data Source

1.2.1 Secondary Sources

1.2.2 Primary Sources

1.3 Disclaimer

2 Porcine Vaccine Market Overview

2.1 Porcine Vaccine Product Overview

2.2 Porcine Vaccine Market Segment by Type

2.2.1 Inactivated Vaccines

2.2.2 Live Attenuated Vaccines

2.2.3 Toxoid Vaccines

2.2.4 Recombinant Vaccines

2.2.5 Conjugate Vaccines

2.2.6 DNA Vaccines

2.3 Global Porcine Vaccine Product Segment by Type

2.3.1 Global Porcine Vaccine Sales (K Doses) and Growth (%) by Type (2013, 2017 and 2025)

2.3.2 Global Porcine Vaccine Sales (K Doses) and Market Share (%) by Type (2013-2018)

2.3.3 Global Porcine Vaccine Revenue (Million USD) and Market Share (%) by Type (2013-2018)

2.3.4 Global Porcine Vaccine Price (USD/Dose) by Type (2013-2018)

2.4 United States Porcine Vaccine Product Segment by Type

2.4.1 United States Porcine Vaccine Sales (K Doses) and Growth by Type (2013, 2017 and 2025)

2.4.2 United States Porcine Vaccine Sales (K Doses) and Market Share by Type (2013-2018)

2.4.3 United States Porcine Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)

2.4.4 United States Porcine Vaccine Price (USD/Dose) by Type (2013-2018)

3 Porcine Vaccine Application/End Users

3.1 Porcine Vaccine Segment by Application/End Users

3.1.1 Veterinary Hospitals

3.1.2 Hog/Pig Production Farm

3.2 Global Porcine Vaccine Product Segment by Application

3.2.1 Global Porcine Vaccine Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)

3.2.2 Global Porcine Vaccine Sales (K Doses) and Market Share (%) by Application (2013-2018)

3.3 United States Porcine Vaccine Product Segment by Application

3.3.1 United States Porcine Vaccine Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)

3.3.2 United States Porcine Vaccine Sales (K Doses) and Market Share (%) by Application (2013-2018)

4 Porcine Vaccine Market Status and Outlook by Regions

4.1 Global Market Status and Outlook by Regions

4.1.1 Global Porcine Vaccine Market Size and CAGR by Regions (2013, 2017 and 2025)

4.1.2 North America

4.1.3 Asia-Pacific

4.1.4 Europe

4.1.5 South America

4.1.6 Middle East and Africa

4.1.7 United States

4.2 Global Porcine Vaccine Sales and Revenue by Regions

4.2.1 Global Porcine Vaccine Sales (K Doses) and Market Share (%) by Regions (2013-2018)

4.2.2 Global Porcine Vaccine Revenue (Million USD) and Market Share (%) by Regions (2013-2018)

4.2.3 Global Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

4.2.4 North America Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

4.2.5 Europe Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

4.2.6 Asia-Pacific Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

4.2.7 South America Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)

4.2.8 Middle East and Africa Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

4.2.9 United States Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)

5 Global Porcine Vaccine Market Competition by Players/Manufacturers

5.1 Global Porcine Vaccine Sales (K Doses) and Market Share by Players (2013-2018)

5.2 Global Porcine Vaccine Revenue (Million USD) and Share by Players (2013-2018)

5.3 Global Porcine Vaccine Average Price (USD/Dose) by Players (2013-2018)

5.4 Global Top Players Porcine Vaccine Manufacturing Base Distribution, Sales Area, Product Types

5.5 Porcine Vaccine Market Competitive Situation and Trends

5.5.1 Porcine Vaccine Market Concentration Rate

5.5.2 Global Porcine Vaccine Market Share (%) of Top 3 and Top 5 Players

5.5.3 Mergers & Acquisitions, Expansion

6 United States Porcine Vaccine Market Competition by Players/Manufacturers

6.1 United States Porcine Vaccine Sales (K Doses) and Market Share by Players (2013-2018)

6.2 United States Porcine Vaccine Revenue (Million USD) and Share by Players (2013-2018)

6.3 United States Porcine Vaccine Average Price (USD/Dose) by Players (2013-2018)

6.4 United States Porcine Vaccine Market Share (%) of Top 3 and Top 5 Players

7 Porcine Vaccine Players/Manufacturers Profiles and Sales Data

7.1 Bayer AG.

7.1.1 Company Basic Information, Manufacturing Base and Competitors

7.1.2 Porcine Vaccine Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Bayer AG. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.1.4 Main Business/Business Overview

7.2 Bimeda Animal Health

7.2.1 Company Basic Information, Manufacturing Base and Competitors

7.2.2 Porcine Vaccine Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Bimeda Animal Health Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.2.4 Main Business/Business Overview

7.3 Boehringer Ingelheim GmbH

7.3.1 Company Basic Information, Manufacturing Base and Competitors

7.3.2 Porcine Vaccine Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Boehringer Ingelheim GmbH Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.3.4 Main Business/Business Overview

7.4 Ceva Sante Animale

7.4.1 Company Basic Information, Manufacturing Base and Competitors

7.4.2 Porcine Vaccine Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Ceva Sante Animale Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.4.4 Main Business/Business Overview

7.5 Eli Lilly

7.5.1 Company Basic Information, Manufacturing Base and Competitors

7.5.2 Porcine Vaccine Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Eli Lilly Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.5.4 Main Business/Business Overview

7.6 Merck & Co., Inc.

7.6.1 Company Basic Information, Manufacturing Base and Competitors

7.6.2 Porcine Vaccine Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Merck & Co., Inc. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.6.4 Main Business/Business Overview

7.7 Merial (Sanofi)

7.7.1 Company Basic Information, Manufacturing Base and Competitors

7.7.2 Porcine Vaccine Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Merial (Sanofi) Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.7.4 Main Business/Business Overview

7.8 Vetoquinol

7.8.1 Company Basic Information, Manufacturing Base and Competitors

7.8.2 Porcine Vaccine Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Vetoquinol Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.8.4 Main Business/Business Overview

7.9 Zoetis, Inc.

7.9.1 Company Basic Information, Manufacturing Base and Competitors

7.9.2 Porcine Vaccine Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Zoetis, Inc. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

7.9.4 Main Business/Business Overview

8 Porcine Vaccine Manufacturing Cost, Industrial Chain and Downstream Buyers

8.1 Porcine Vaccine Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Porcine Vaccine Industrial Chain Analysis

8.4 Downstream Buyers in United States

9 Marketing Strategy Analysis, Distributors and Market Effect Factors

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Distributors in Untied States

9.3 Market Effect Factors Analysis

9.3.1 Economic/Political Environmental Change

9.3.2 Downstream Demand Change

9.3.3 Technology Progress in Related Industry

9.3.4 Substitutes Threat

10 Global Porcine Vaccine Market Forecast

10.1 Global Porcine Vaccine Sales, Revenue Forecast (2018-2025)

10.1.1 Global Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

10.1.1 Global Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

10.2 United States Porcine Vaccine Market Forecast

10.2.1 United States Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

10.2.2 United States Porcine Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)

10.3 Global Porcine Vaccine Forecast by Regions

10.3.1 North America Porcine Vaccine Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)

10.3.2 Europe Porcine Vaccine Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)

10.3.3 Asia-Pacific Porcine Vaccine Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)

10.3.4 South America Porcine Vaccine Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)

10.3.5 Middle East and Africa Porcine Vaccine Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)

10.4 Porcine Vaccine Forecast by Type

10.4.1 Global Porcine Vaccine Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)

10.4.2 United States Porcine Vaccine Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)

10.5 Porcine Vaccine Forecast by Application

10.5.1 Global Porcine Vaccine Sales (K Doses) Forecast by Application (2018-2025)

10.5.2 United States Porcine Vaccine Sales (K Doses) Forecast by Application (2018-2025)

11 Research Findings and Conclusion

List of Tables and Figures

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

Figure Porcine Vaccine Product Picture

Figure Global Porcine Vaccine Revenue (Million USD) Status and Outlook (2013-2025)

Figure United States Porcine Vaccine Revenue (Million USD) Status and Outlook (2013-2025)

Figure Product Picture of Inactivated Vaccines

Table Major Players of Inactivated Vaccines

Figure Global Inactivated Vaccines Sales (K Doses) and Growth Rate (%)(2013-2018)

Figure Product Picture of Live Attenuated Vaccines

Table Major Players of Live Attenuated Vaccines

Figure Global Live Attenuated Vaccines Sales (K Doses) and Growth Rate (%)(2013-2018)

Figure Product Picture of Toxoid Vaccines

Table Major Players of Toxoid Vaccines

Figure Global Toxoid Vaccines Sales (K Doses) and Growth Rate (%)(2013-2018)

Figure Product Picture of Recombinant Vaccines

Table Major Players of Recombinant Vaccines

Figure Global Recombinant Vaccines Sales (K Doses) and Growth Rate (%)(2013-2018)

Figure Product Picture of Conjugate Vaccines

Table Major Players of Conjugate Vaccines

Figure Global Conjugate Vaccines Sales (K Doses) and Growth Rate (%)(2013-2018)

Figure Product Picture of DNA Vaccines

Table Major Players of DNA Vaccines

Figure Global DNA Vaccines Sales (K Doses) and Growth Rate (%)(2013-2018)

Table Global Porcine Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)

Table Global Porcine Vaccine Sales (K Doses) by Type (2013-2018)

Table Global Porcine Vaccine Sales Share (%) by Type (2013-2018)

Figure Global Porcine Vaccine Sales Market Share (%) by Type (2013-2018)

Figure Global Porcine Vaccine Sales Market Share (%) by Type in 2017

Table Global Porcine Vaccine Revenue (Million USD) by Type (2013-2018)

Table Global Porcine Vaccine Revenue Share (%) by Type (2013-2018)

Figure Global Porcine Vaccine Revenue Share (%) by Type (2013-2018)

Figure 2017 Global Porcine Vaccine Revenue Market Share (%) by Type

Table Global Porcine Vaccine Price (USD/Dose) by Type (2013-2018)

Table United States Porcine Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)

Table United States Porcine Vaccine Sales (K Doses) by Type (2013-2018)

Table United States Porcine Vaccine Sales Share (%) by Type (2013-2018)

Figure United States Porcine Vaccine Sales Market Share (%) by Type (2013-2018)

Figure United States Porcine Vaccine Sales Market Share (%) by Type in 2017

Table United States Porcine Vaccine Revenue (Million USD) by Type (2013-2018)

Table United States Porcine Vaccine Revenue Share (%) by Type (2013-2018)

Figure United States Porcine Vaccine Revenue Share (%)by Type (2013-2018)

Figure 2017 United States Porcine Vaccine Revenue Market Share (%) by Type

Table United States Porcine Vaccine Price (USD/Dose) by Type (2013-2018)

Figure Veterinary Hospitals Examples

Figure Hog/Pig Production Farm Examples

Table Global Porcine Vaccine Sales (K Doses) Comparison by Application (2013-2025)

Table Global Porcine Vaccine Sales (K Doses) by Application (2013-2018)

Table Global Porcine Vaccine Sales Share (%) by Application (2013-2018)

Figure Global Porcine Vaccine Sales Market Share (%) by Application (2013-2018)

Figure Global Porcine Vaccine Sales Market Share (%) by Application in 2017

Table United States Porcine Vaccine Sales (K Doses) Comparison by Application (2013-2025)

Table United States Porcine Vaccine Sales (K Doses) by Application (2013-2018)

Table United States Porcine Vaccine Sales Share (%) by Application (2013-2018)

Figure United States Porcine Vaccine Sales Market Share (%) by Application (2013-2018)

Figure United States Porcine Vaccine Sales Market Share (%) by Application in 2017

Table Global Porcine Vaccine Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)

Figure North America Porcine Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

Figure Asia-Pacific Porcine Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

Figure Europe Porcine Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

Figure South America Porcine Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

Figure Middle East and Africa Porcine Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

Figure United States Porcine Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

Table Global Porcine Vaccine Sales (K Doses) by Regions (2013-2018)

Figure Global Porcine Vaccine Sales Market Share (%) by Regions (2013-2018)

Figure Global Porcine Vaccine Sales Market Share (%) by Regions (2013-2018)

Figure 2017 Global Porcine Vaccine Sales Market Share (%) by Regions

Figure 2017 United States Porcine Vaccine Sales Market Share (%) in Global Market

Table Global Porcine Vaccine Revenue (Million USD) by Regions (2013-2018)

Table Global Porcine Vaccine Revenue Market Share (%) by Regions (2013-2018)

Figure Global Porcine Vaccine Revenue Market Share (%) by Regions (2013-2018)

Figure 2017 Global Porcine Vaccine Revenue Market Share (%) by Regions

Figure 2017 United States Porcine Vaccine Revenue Market Share (%) in Global Market

Table Global Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Table North America Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Table Europe Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Table Asia-Pacific Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Table South America Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Table Middle East and Africa Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Table United States Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Table Global Porcine Vaccine Sales (K Doses) of Key Players (2013-2018)

Table Global Porcine Vaccine Sales Share (%) by Players (2013-2018)

Figure 2017 Global Porcine Vaccine Sales Share (%) by Players

Figure 2018 Global Porcine Vaccine Sales Share (%) by Players

Table Global Porcine Vaccine Revenue (Million USD) by Players (2013-2018)

Table Global Porcine Vaccine Revenue Share (%) by Players (2013-2018)

Table 2017 Global Porcine Vaccine Revenue Share (%) by Players

Table 2017 Global Porcine Vaccine Revenue Share (%) by Players

Table Global Market Porcine Vaccine Average Price (USD/Dose) by Players (2013-2018)

Table Global Porcine Vaccine Top Players Manufacturing Base Distribution and Sales Area

Table Global Porcine Vaccine Top Players Product Category

Figure Global Porcine Vaccine Market Share (%) of Top 3 Players

Figure Global Porcine Vaccine Market Share (%) of Top 5 Players

Table United States Porcine Vaccine Sales (K Doses) by Players (2013-2018)

Table United States Porcine Vaccine Sales Market Share (%) by Players (2013-2018)

Figure 2017 United States Porcine Vaccine Sales Share (%) by Players

Figure 2018 United States Porcine Vaccine Sales Share (%) by Players

Table United States Porcine Vaccine Revenue (Million USD) by Players (2013-2018)

Table United States Porcine Vaccine Revenue Market Share (%) by Players (2013-2018)

Table 2017 United States Porcine Vaccine Revenue Share (%) by Players

Table 2017 United States Porcine Vaccine Revenue Share (%) by Players

Table United States Market Porcine Vaccine Average Price (USD/Dose) by Players (2013-2018)

Figure United States Porcine Vaccine Market Share (%) of Top 3 Players

Figure United States Porcine Vaccine Market Share (%) of Top 5 Players

Table Bayer AG. Basic Information List

Table Bayer AG. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Bayer AG. Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Bayer AG. Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Bayer AG. Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Bimeda Animal Health Basic Information List

Table Bimeda Animal Health Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Bimeda Animal Health Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Bimeda Animal Health Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Bimeda Animal Health Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Boehringer Ingelheim GmbH Basic Information List

Table Boehringer Ingelheim GmbH Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Boehringer Ingelheim GmbH Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Boehringer Ingelheim GmbH Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Boehringer Ingelheim GmbH Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Ceva Sante Animale Basic Information List

Table Ceva Sante Animale Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Ceva Sante Animale Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Ceva Sante Animale Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Ceva Sante Animale Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Eli Lilly Basic Information List

Table Eli Lilly Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Eli Lilly Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Eli Lilly Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Eli Lilly Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Merck & Co., Inc. Basic Information List

Table Merck & Co., Inc. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Merck & Co., Inc. Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Merck & Co., Inc. Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Merck & Co., Inc. Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Merial (Sanofi) Basic Information List

Table Merial (Sanofi) Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Merial (Sanofi) Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Merial (Sanofi) Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Merial (Sanofi) Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Vetoquinol Basic Information List

Table Vetoquinol Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Vetoquinol Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Vetoquinol Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Vetoquinol Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Zoetis, Inc. Basic Information List

Table Zoetis, Inc. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

Figure Zoetis, Inc. Porcine Vaccine Sales Growth Rate (2013-2018)

Figure Zoetis, Inc. Porcine Vaccine Sales Global Market Share (%)(2013-2018)

Figure Zoetis, Inc. Porcine Vaccine Revenue Global Market Share (%)(2013-2018)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Porcine Vaccine

Figure Porcine Vaccine Industrial Chain Analysis

Table Major Buyers of Porcine Vaccine

Table Distributors/Traders List

Figure Global Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

Figure Global Porcine Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)

Figure United States Porcine VaccinePorcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

Figure United States Porcine Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)

Table Global Porcine Vaccine Sales (K Doses) Forecast by Regions (2018-2025)

Figure Global Porcine Vaccine Sales Market Share (%) Forecast by Regions (2018-2025)

Figure North America Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

Figure North America Porcine Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

Figure Europe Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

Figure Europe Porcine Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

Figure Asia-Pacific Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

Figure Asia-Pacific Porcine Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

Figure South America Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

Figure South America Porcine Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

Figure Middle East and Africa Porcine Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

Figure Middle East and Africa Porcine Vaccine Revenue and Growth Rate (%) Forecast (2018-2025)

Table Global Porcine Vaccine Sales (Million USD) Forecast by Type (2018-2025)

Figure Global Porcine Vaccine Sales Market Share (%) Forecast by Type (2018-2025)

Table Global Porcine Vaccine Revenue (Million USD) Forecast by Type (2018-2025)

Figure Global Porcine Vaccine Revenue Market Share (%) Forecast by Type (2018-2025)

Table United States Porcine Vaccine Sales (Million USD) Forecast by Type (2018-2025)

Figure United States Porcine Vaccine Sales Market Share (%) Forecast by Type (2018-2025)

Table United States Porcine Vaccine Revenue (Million USD) Forecast by Type (2018-2025)

Figure United States Porcine Vaccine Revenue Market Share (%) Forecast by Type (2018-2025)

Table Global Porcine Vaccine Sales (K Doses) Forecast by Application (2018-2025)

Figure Global Porcine Vaccine Sales Forecast by Application (2018-2025)

Table United States Porcine Vaccine Sales (K Doses) Forecast by Application (2018-2025)

Figure United States Porcine Vaccine Sales Forecast by Application (2018-2025)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research